Kimia Biosciences Ltd

Kimia Bioscien. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Kimia Biosciences Ltd

₹ 46.2 0.46%
23 Dec - close price
kimiabiosciences.com BSE: 530313
About

Incorporated in 1993, Kimia Biosciences Ltd
is in the business of Pharmaceutical products[1]

Key Points

Product Profile:[1][2]
Company manufactures Active Pharmaceuticals Ingredients. It has commercialized 25+ products with 9-10 molecules under development

Website BSE
  • Market Cap ₹ 219 Cr.
  • Current Price ₹ 46.2
  • High / Low ₹ 58.4 / 33.2
  • Stock P/E 75.4
  • Book Value ₹ 0.71
  • Dividend Yield 0.00 %
  • ROCE -4.16 %
  • ROE -183 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company's working capital requirements have reduced from 68.3 days to 47.2 days

Cons

  • Stock is trading at 64.7 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 2.23% over past five years.
  • Company has a low return on equity of -58.5% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
30.93 33.22 29.88 36.58 40.47 28.80 22.66 24.23 24.20 26.14 30.30 22.40 28.18
31.29 33.57 30.25 33.91 39.79 31.75 28.02 25.87 26.16 27.19 26.14 18.69 24.81
Operating Profit -0.36 -0.35 -0.37 2.67 0.68 -2.95 -5.36 -1.64 -1.96 -1.05 4.16 3.71 3.37
OPM % -1.16% -1.05% -1.24% 7.30% 1.68% -10.24% -23.65% -6.77% -8.10% -4.02% 13.73% 16.56% 11.96%
0.32 0.22 0.22 0.45 0.13 0.26 -0.69 0.13 0.64 0.58 0.30 0.08 0.37
Interest 0.90 0.90 1.05 0.83 1.10 1.05 1.26 1.28 1.12 1.31 1.34 1.11 1.04
Depreciation 0.76 0.77 0.75 0.80 0.82 0.84 0.87 0.83 0.82 0.82 0.82 0.90 0.79
Profit before tax -1.70 -1.80 -1.95 1.49 -1.11 -4.58 -8.18 -3.62 -3.26 -2.60 2.30 1.78 1.91
Tax % -25.29% -25.56% -27.69% 26.17% -26.13% -24.45% -24.57% -25.14% -25.15% -25.00% 22.17% 19.66% 15.71%
-1.27 -1.35 -1.41 1.10 -0.83 -3.46 -6.17 -2.71 -2.44 -1.95 1.80 1.44 1.61
EPS in Rs -0.27 -0.29 -0.30 0.23 -0.18 -0.73 -1.30 -0.57 -0.52 -0.41 0.38 0.30 0.34
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
12 6 2 0 1 76 94 106 133 125 129 105 107
10 7 4 4 2 74 88 102 124 124 133 105 97
Operating Profit 2 -0 -2 -3 -1 2 6 4 8 1 -5 -0 10
OPM % 16% -5% -110% -1,779% -56% 3% 6% 4% 6% 0% -4% -0% 10%
0 0 1 0 0 1 1 1 2 1 0 2 1
Interest 0 0 0 1 0 1 2 3 3 4 4 5 5
Depreciation 0 0 0 0 0 1 1 2 2 3 3 3 3
Profit before tax 1 -1 -2 -4 -1 2 4 1 6 -5 -12 -7 3
Tax % 6% -1% 1% 0% -8% -4% -1% -13% 8% -26% -25% -26%
1 -1 -2 -4 -1 2 4 1 5 -4 -9 -5 3
EPS in Rs 1.71 -1.06 -2.30 -5.48 -1.26 2.26 2.64 0.30 1.08 -0.78 -1.98 -1.12 0.61
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 32%
5 Years: 2%
3 Years: -8%
TTM: 7%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 121%
Stock Price CAGR
10 Years: %
5 Years: 16%
3 Years: 5%
1 Year: 25%
Return on Equity
10 Years: %
5 Years: -20%
3 Years: -58%
Last Year: -183%

Balance Sheet

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 7 7 7 7 7 1 1 5 5 5 5 5 5
Reserves -5 -6 -7 -11 -12 0 4 9 14 10 1 -4 -1
1 0 1 7 14 34 31 34 45 41 53 44 39
2 3 4 1 3 22 29 38 43 54 63 56 57
Total Liabilities 6 6 5 4 12 58 65 86 107 109 121 100 99
4 4 3 3 7 13 16 18 28 35 34 32 31
CWIP 0 0 0 0 3 2 2 6 6 0 1 1 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
2 2 1 1 2 43 48 62 72 74 87 68 68
Total Assets 6 6 5 4 12 58 65 86 107 109 121 100 99

Cash Flows

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
1 1 0 -6 -1 -7 -3 0 6 8 -7 15
-1 -0 0 -0 -6 -2 -2 -9 -14 -1 -3 -1
-1 -0 -0 6 7 10 4 8 8 -8 10 -13
Net Cash Flow -0 -0 -0 0 0 0 -0 0 0 -0 -0 -0

Ratios

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 41 22 56 173 20 141 113 128 115 88 87 96
Inventory Days 75 50 319 615 59 83 92 89 146 183 149
Days Payable 988 667 91 511 120 91 121 116 159 177 194
Cash Conversion Cycle 41 -891 -560 401 124 80 105 100 88 76 93 51
Working Capital Days -10 -58 -530 -173 -1,358 70 83 94 98 78 79 47
ROCE % 46% -25% -127% -188% -10% 10% 16% 9% 16% -2% -12% -4%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
74.94% 74.94% 74.94% 74.94% 74.94% 74.94% 74.94% 74.94% 74.94% 74.94% 74.94% 74.94%
0.38% 0.38% 0.38% 0.38% 0.38% 0.38% 0.38% 0.38% 0.38% 0.38% 0.38% 0.38%
24.68% 24.68% 24.67% 24.68% 24.68% 24.67% 24.68% 24.67% 24.66% 24.67% 24.68% 24.67%
No. of Shareholders 12,21212,51012,45412,39912,24312,20112,14712,11812,06312,11012,02312,179

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports